USPTO serial 98475685
NU.Q
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- LATTUCA, FRANK J
- Law office
- TMEG LAW OFFICE 109
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NU.Q?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Amanda G. Hyland
Amanda G. Hyland Buchalter LLP3475 Piedmont Road NESTE 1100Atlanta, GA 30305Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 044 | Medical services and veterinary services; diagnostic testing and treatment of human and animal patients with disorders, namely, cancer, sepsis,COVID-19, infection, dementia, Alzheimer's disease, transplant health, thrombosis, vascular damage, inflammation, disorders associated with the immune system and disorders associated with neutrophil extracellular traps (NETs); medical analysis services relating to the treatment of persons and animals; health care; hospital services; veterinary advisory services; human and animal tissue bank services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical clinic services; medical screening; medical equipment rental; epigenetic profiling services for diagnosing disease, monitoring disease and treatment efficacy; medical analysis for the diagnosis and treatment of persons and animals; genetic testing of humans or animals for diagnostic or treatment purposes; Medical or veterinary RNA or DNA analysis for screening for cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant health, thrombosis, vascular damage, inflammation, disorders associated with the immune system and disorders associated with neutrophil extracellular traps (NETs); diagnosis and prognosis for use in the fields of epigenetics and nucleosomes; genetic testing for medical or veterinary purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 9, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 9, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 9, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 8, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 8, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 5, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 28, 2026 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Oct 28, 2026 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 28, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 30, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 30, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 30, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 29, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 29, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 27, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 24, 2026 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Apr 24, 2026 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Apr 24, 2026 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 10, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 10, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 10, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 9, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 9, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 9, 2025 | ALIE | ASSIGNED TO LIE | — |
| Oct 3, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Sep 9, 2025 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Sep 9, 2025 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Sep 9, 2025 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jul 5, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 4, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 4, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 4, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 3, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 3, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 3, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 15, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 15, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 15, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 10, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 4, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 4, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 4, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 4, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 4, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 1, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 29, 2024 | NWAP | NEW APPLICATION ENTERED | — |